A podcast series from Medtronic that goes straight to your ears to your heart. Join cardiac surgery professionals as they discuss recent developments in patient care, advancements in therapy technology and share personal experiences.
Penditure Exclusion System: Left Atrial Appendage ManagementHost: Pieter KappeteinGuests:Dr. Robert Hawkins – Frankel Cardiovascular Center, University of MichiganDr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia Segment 2: Robotic Closure, Appendage management for all AFib patients
Penditure Exclusion System: Left Atrial Appendage ManagementHost: Pieter KappeteinGuests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of MichiganDr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia Segment 1: Candidates, Circumstances, Clip Placement
Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.
Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.
Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.
Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.
Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.
Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.
Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.
Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.
Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.
Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery Residents for a candid chat. James Bailey, Tessa Watt, Daniel Ziazadeh, and Natalie Ostro talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.
Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery Residents for a candid chat. James Bailey, Tessa Watt, Daniel Ziazadeh, and Natalie Ostro talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.
Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery Residents for a candid chat. James Bailey, Tessa Watt, Daniel Ziazadeh, and Natalie Ostro talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.
Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.
Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.
Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.
Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.
Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.
Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.
Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.
A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.
A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.
In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.
In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.
In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.
In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.
Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference.
Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference.
There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania, Dr. Bob Kiaii from UC Davis Medical Center and Dr. Maral Ouzounian from the Toronto General Hospital as they discuss the lifetime management of surgical aortic valve replacement patients.
There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania, Dr. Bob Kiaii from UC Davis Medical Center and Dr. Maral Ouzounian from the Toronto General Hospital as they discuss the lifetime management of surgical aortic valve replacement patients.
There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania, Dr. Bob Kiaii from UC Davis Medical Center and Dr. Maral Ouzounian from the Toronto General Hospital as they discuss the lifetime management of surgical aortic valve replacement patients.
Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the role of total arterial revascularization, minimally invasive approaches, and learning outside of the fellowship.
Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the role of total arterial revascularization, minimally invasive approaches, and learning outside of the fellowship.
Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the role of total arterial revascularization, minimally invasive approaches, and learning outside of the fellowship.
Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way.
Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way.
Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way.
The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward.
The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward.
The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward.